Valori, C. F., Possenti, A., Brambilla, L. & Rossi, D. Challenges and opportunities of targeting astrocytes to halt neurodegenerative disorders. Cells 10, 2019 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Prabakaran, A. et al. Nose-to-brain drug delivery for the treatment of Alzheimer’s disease: current advancements and challenges. Expert Opin. Drug Deliv. 19, 87–102 (2022).

Article  Google Scholar 

Markowicz-Piasecka, M. et al. Current approaches to facilitate improved drug delivery to the central nervous system. Eur. J. Pharm. Biopharm. 181, 249–262 (2022).

Article  CAS  PubMed  Google Scholar 

Doody, R. S. et al. A phase 3 trial of semagacestat for treatment of Alzheimer’s disease. N. Engl. J. Med. 369, 341–350 (2013).

Article  CAS  PubMed  Google Scholar 

Imbimbo, B. P. & Giardina, G. A. M. γ-Secretase inhibitors and modulators for the treatment of Alzheimer’s disease: disappointments and hopes. Curr. Top. Med. Chem. 11, 1555–1570 (2011).

Article  CAS  PubMed  Google Scholar 

Kouhi, A. et al. Brain disposition of antibody-based therapeutics: dogma, approaches and perspectives. Int. J. Mol. Sci. 22, 6442 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chang, H.-Y. et al. Brain pharmacokinetics of anti-transferrin receptor antibody affinity variants in rats determined using microdialysis. mAbs 13, 1874121 (2021).

Article  PubMed  PubMed Central  Google Scholar 

Keiser, M. S. et al. Toxicity after AAV delivery of RNAi expression constructs into nonhuman primate brain. Nat. Med. 27, 1982–1989 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ling, Q., Herstine, J. A., Bradbury, A. & Gray, S. J. AAV-based in vivo gene therapy for neurological disorders. Nat. Rev. Drug Discov. 22, 789–806 (2023).

Article  CAS  PubMed  Google Scholar 

Lee, H. et al. Multi-omic analysis of selectively vulnerable motor neuron subtypes implicates altered lipid metabolism in ALS. Nat. Neurosci. 24, 1673–1685 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Herb, B. R. et al. Single-cell genomics reveals region-specific developmental trajectories underlying neuronal diversity in the human hypothalamus. Sci. Adv. 9, eadf6251 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vialle, R. A., de Paiva Lopes, K., Bennett, D. A., Crary, J. F. & Raj, T. Integrating whole-genome sequencing with multi-omic data reveals the impact of structural variants on gene regulation in the human brain. Nat. Neurosci. 25, 504–514 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yao, Z. et al. A high-resolution transcriptomic and spatial atlas of cell types in the whole mouse brain. Nature 624, 317–332 (2023). This article introduces a collaborative effort from the BRAIN Initiative Cell Census Network, presenting cellular maps of the mouse brain with high spatial resolution.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chini, M. & Hanganu-Opatz, I. L. Prefrontal cortex development in health and disease: lessons from rodents and humans. Trends Neurosci. 44, 227–240 (2021).

Article  CAS  PubMed  Google Scholar 

Fu, H., Hardy, J. & Duff, K. E. Selective vulnerability in neurodegenerative diseases. Nat. Neurosci. 21, 1350–1358 (2018). This paper provides a comprehensive overview of the current understanding of biological mechanisms underpinning selective neuronal and regional vulnerability in neurological disorders.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Goodkind, M. et al. Identification of a common neurobiological substrate for mental illness. JAMA Psychiatry 72, 305–315 (2015).

Article  PubMed  PubMed Central  Google Scholar 

Del Tredici, K., Rüb, U., De Vos, R. A. I., Bohl, J. R. E. & Braak, H. Where does Parkinson disease pathology begin in the brain? J. Neuropathol. Exp. Neurol. 61, 413–426 (2002).

Article  PubMed  Google Scholar 

De Marchi, F. et al. Cognitive dysfunction in amyotrophic lateral sclerosis: can we predict it? Neurol. Sci. 42, 2211–2222 (2021).

Article  PubMed  PubMed Central  Google Scholar 

Crockford, C. et al. ALS-specific cognitive and behavior changes associated with advancing disease stage in ALS. Neurology 91, e1370–e1380 (2018).

Article  PubMed  PubMed Central  Google Scholar 

Lassmann, H. Multiple sclerosis pathology. Cold Spring Harb. Perspect. Med. 8, a028936 (2018).

Article  PubMed  PubMed Central  Google Scholar 

Haider, L. et al. The topograpy of demyelination and neurodegeneration in the multiple sclerosis brain. Brain 139, 807–815 (2016).

Article  PubMed  PubMed Central  Google Scholar 

Knopman, D. S. et al. Alzheimer disease. Nat. Rev. Dis. Primers 7, 33 (2021).

Article  PubMed  PubMed Central  Google Scholar 

Schöll, M. et al. Biomarkers for tau pathology. Mol. Cell. Neurosci. 97, 18–33 (2019).

Article  PubMed  PubMed Central  Google Scholar 

Musolino, P. L. et al. Brain endothelial dysfunction in cerebral adrenoleukodystrophy. Brain 138, 3206–3220 (2015).

Article  PubMed  PubMed Central  Google Scholar 

Pong, S., Karmacharya, R., Sofman, M., Bishop, J. R. & Lizano, P. The role of brain microvascular endothelial cell and blood-brain barrier dysfunction in schizophrenia. Complex Psychiatry 6, 30–46 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Estudillo, E. et al. Thinking outside the black box: are the brain endothelial cells the new main target in Alzheimer’s disease? Neural Regen. Res. 18, 2592 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang, A. C. et al. A human brain vascular atlas reveals diverse mediators of Alzheimer’s risk. Nature 603, 885–892 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mrdjen, D. et al. The basis of cellular and regional vulnerability in Alzheimer’s disease. Acta Neuropathol. 138, 729–749 (2019).

Article  PubMed  PubMed Central  Google Scholar 

Bennett, H. C. & Kim, Y. Pericytes across the lifetime in the central nervous system. Front. Cell. Neurosci. 15, 627291 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Giguère, N., Burke Nanni, S. & Trudeau, L.-E. On cell loss and selective vulnerability of neuronal populations in Parkinson’s disease. Front. Neurol. 9, 455 (2018).

Article  PubMed  PubMed Central